Polycomb	O
complexes	O
associate	O
with	O
enhancers	O
and	O
promote	O
oncogenic	O
transcriptional	O
programs	O
in	O
cancer	O
through	O
multiple	O
mechanisms	O
.	O


Polycomb	O
repressive	O
complex	O
1	O
(	O
PRC1	O
)	O
plays	O
essential	O
roles	O
in	O
cell	O
fate	O
decisions	O
and	O
development	O
.	O


However	O
,	O
its	O
role	O
in	O
cancer	O
is	O
less	O
well	O
understood	O
.	O


Here	O
,	O
we	O
show	O
that	O
RNF2	O
,	O
encoding	O
RING1B	O
,	O
and	O
canonical	O
PRC1	O
(	O
cPRC1	O
)	O
genes	O
are	O
overexpressed	O
in	O
breast	O
cancer	O
.	O


We	O
find	O
that	O
cPRC1	O
complexes	O
functionally	O
associate	O
with	O
ERalpha	O
and	O
its	O
pioneer	O
factor	O
FOXA1	O
in	O
ER	B-TISSUE
+	I-TISSUE
breast	I-TISSUE
cancer	I-TISSUE
cells	E-TISSUE
,	O
and	O
with	O
BRD4	O
in	O
triple	B-TISSUE
-	I-TISSUE
negative	I-TISSUE
breast	I-TISSUE
cancer	I-TISSUE
cells	E-TISSUE
(	O
TNBC	O
)	O
.	O


While	O
cPRC1	O
still	O
exerts	O
its	O
repressive	O
function	O
,	O
it	O
is	O
also	O
recruited	O
to	O
oncogenic	O
active	O
enhancers	O
.	O


RING1B	O
regulates	O
enhancer	O
activity	O
and	O
gene	O
transcription	O
not	O
only	O
by	O
promoting	O
the	O
expression	O
of	O
oncogenes	O
but	O
also	O
by	O
regulating	O
chromatin	O
accessibility	O
.	O


Functionally	O
,	O
RING1B	O
plays	O
a	O
divergent	O
role	O
in	O
ER	O
+	O
and	O
TNBC	O
metastasis	O
.	O


Finally	O
,	O
we	O
show	O
that	O
concomitant	O
recruitment	O
of	O
RING1B	O
to	O
active	O
enhancers	O
occurs	O
across	O
multiple	O
cancers	O
,	O
highlighting	O
an	O
under	O
-	O
explored	O
function	O
of	O
cPRC1	O
in	O
regulating	O
oncogenic	O
transcriptional	O
programs	O
in	O
cancer	O
.	O
